Evaluating Trifluridine/Tipiracil Based Chemoradiation in Locally Advanced Rectal Cancer - The Phase I/II TARC Trial

Stopped Due to the amended therapy strategies for rectal cancer recently, it was decided not to transfer the study to the phase II part, as superiority over standard chemoradiation and transfer to a new therapy standard are increasingly unlikely.

Conditions

• Locally Advanced Rectal Cancer

Interventions

• COMBINATION_PRODUCT: Trifluridine/tipiracil chemoradiation
• COMBINATION_PRODUCT: Capecitabine based chemoradiation

Sponsor

Universitätsklinikum Hamburg-Eppendorf

Collaborators

• [object Object]
• [object Object]